MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Higher genetic load is associated with an earlier disease onset but not with more rapid disease progression in Parkinson’s disease

    S. Lerche, I. Wurster, B. Roeben, E. Schaeffer, C. Schulte, S. Akbas, A.-K. Hauser, C. Deuschle, T. Gasser, D. Berg, K. Brockmann (Tuebingen, Germany)

    Objective: To evaluate the influence of genetic variants on phenotypic variability and disease progression in PD patients. Background: Parkinson’s disease (PD) patients show a large…
  • 2017 International Congress

    A neuronal model of PARK20 (SYNJ1 mutation) using patient derived iPSCs

    R. Masius, M. Minneboo, M. Grochowska, M. Quadri, M. Picillo, P. Barone, V. Bonifati, W. Mandemakers (Rotterdam, Netherlands)

    Objective: The SYNJ1 homozygous mutation (p.Arg258Gln) leads to juvenile Parkinsonism (PARK20). SYNJ1 plays an important role in synaptic vesicle cycling, and regulating autophagic flux. We…
  • 2017 International Congress

    Glucocerebrosidase mutations in neurodegenerative disorders other than Parkinson’s disease

    G. Buongarzone, C. Fenoglio, J. Nicoli, E. Monfrini, I. Trezzi, A. Arighi, R. Del Bo, N. Bresolin, E. Scarpini, G. Comi, S. Corti, A. Di Fonzo (Milan, Italy)

    Objective: To determinate the frequencies of lysosomal glucocerebrosidase (GBA) common mutations in a large sample of neurodegenerative diseases including Alzheimer Disease (AD), Lewy Body Dementia (LBD), Amyotrophic…
  • 2017 International Congress

    Parkinson’s disease GWAS risk loci and symptom progression

    K. Paul, J. Schulz, J. Bronstein, C. Lill, B. Ritz (los angeles, CA, USA)

    Objective: To assess whether GWAS identified Parkinson’s disease (PD) risk loci also influence symptom progression among patients.  Background: Genetic factors have a considerable influence on…
  • 2017 International Congress

    Predictors of onset of psychosis in Parkinson’s disease: “Who gets it early?”

    P. Pal, A. Lenka, L. George, S. Arumugham, S. Hegde, N. Kamble, R. Yadav (Bangalore, India)

    Objective: To explore the factors which may predict the onset of psychosis in Parkinson’s disease (PD). Background: Non-motor symptoms (NMS) are commonly observed in PD.…
  • 2017 International Congress

    Delusional Misidentification Syndrome for “Self” in two patients with Parkinson`s Disease.

    S. Ray, D. Park, D. Burdick, A. Griffith, J. Shaw, P. Agarwal (Kirkland, WA, USA)

    Objective:  We report two patients with Parkinson’s disease(PD) and Capgras syndrome (CS) with confusion of identify not just of close acquaintances but also of “self”.…
  • 2017 International Congress

    Mirror Movements in extrapiramidal diseases

    A. Manin, S. Rodríguez-Quiroga, L. Piedrafita Vico, N. Larripa, L. Assante, J. Casen, T. Arakaki, N. Garretto (Buenos Aires, Argentina)

    Objective:  To analyze the presence of mirror movements (MM) in different extrapiramidal diseases. Background: MM are involuntary movements that appear during voluntary activity in contralateral…
  • 2017 International Congress

    Fatigue in Functional Motor Disorders.

    J. Gelauff, E. Kingma, J. Stone, J. Rosmalen, M. Tijssen (Groningen, Netherlands)

    Objective: To investigate fatigue severity and the nature of fatigue in functional motor disorders (FMD). Secondarily, to determine the relationship between fatigue, quality of life,…
  • 2017 International Congress

    A Comparison of Muscular Atrophy Between Botulinum Toxin Types A and B

    F. Amjad, F. Pagan, A. Lax, C. Moussa (Washington DC, DC, USA)

    Objective: To compare and quantify the degree of muscular atrophy (MA) in botulinum toxin (BT) type A (Botox) and type B (Myobloc). A secondary endpoint…
  • 2017 International Congress

    Effect of Personal Characteristics on Semiology of the First Tic Episode in Children with Tourette Syndrome

    J. Oražem Mrak, J. Kodrič, D. Osredkar, D. Neubauer (Ljubljana, Slovenia)

    Objective: to determine the correlation between personal characteristics and semiology of the first tic episode in children with Tourette syndrome. Background: there is a lack…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley